APTX
Aptinyx Inc.
Set alert
0.10 USD 0.00 0.00%
0.09 Day range 0.096
0.009 52-week range 0.72
- Open
- 0.09155
- Prev close
- 0.096
- Mkt cap
- 0
- Vol
- 231.13K
- Avg vol
- 132.92K
- EPS
- -0.98
- P/E
- -0.10
- Div yield
- 0.00%
More statistics
- Low
- 0.09
- High
- 0.096
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 2, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Jan 2, 2024
Expected Jan 2, 2024. Consensus EPS estimate 0.00.
Financials — quick view
APTX Revenue — quarterly 0
APTX Net income — quarterly -21.07M
APTX EPS — quarterly -0.31
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 2, 2024 | Sep 1, 2023 | -0.05 | — | — | — |
| Oct 5, 2023 | Jun 1, 2023 | -0.05 | — | — | — |
| May 18, 2023 | Mar 1, 2023 | -0.23 | — | — | — |
| Mar 30, 2023 | Dec 1, 2022 | -0.19 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | -0.24 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | -0.29 | — | — | — |
News
- Apotex Health Corp. (APTX) Opens the Market
- Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO
- Stocks That Hit 52-Week Lows On Friday
- Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives
- Here's Why Aptinyx Inc. (APTX) Is a Great 'Buy the Bottom' Stock Now
- COYA, Dr. Reddy's Sign Deal for Proposed Abatacept Biosimilar
- Stocks That Hit 52-Week Lows On Wednesday
- Stocks That Hit 52-Week Lows On Wednesday
- Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
- Stocks That Hit 52-Week Lows On Wednesday
Your note
Sign in to keep a note on APTX — it syncs with the Stock Master app.